Disc Medicine, Inc.

53.78 USD
+0.41 (+0.77%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Disc Medicine, Inc. stock is up 18.96% since 30 days ago. The next earnings date is Apr 1, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 November’s closed higher than October. In the last 1 Unusual Options Trades, there were 1 CALL.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
19 Oct 19:26 15 Dec, 2023 50.00 CALL 24 282

About Disc Medicine, Inc.

Gemini Therapeutics, Inc. engages in developing therapeutic compounds for treating genetically defined age-related macular degeneration (AMD) Its lead candidate is GEM103, a recombinant form of the human complement factor H protein. The company also develops GEM307 for treatment of systemic diseases.